Hydronephrosis surgery

Jump to navigation Jump to search

Hydronephrosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hydronephrosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hydronephrosis surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hydronephrosis surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hydronephrosis surgery

CDC on Hydronephrosis surgery

Hydronephrosis surgery in the news

Blogs on Hydronephrosis surgery

Directions to Hospitals Treating Hydronephrosis

Risk calculators and risk factors for Hydronephrosis surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]

Overview

  • Surgery is the mainstay of treatment for Hydronephrosis. The type of surgery depends on the underlying cause and also depending on whether the obstruction is acute or chronic.

Surgery

Treatment of hydronephrosis focuses upon the removal of the obstruction and drainage of the urine that has accumulated behind the obstruction. Therefore, the specific treatment depends upon where the obstruction lies, and whether it is acute or chronic.

Acute obstruction of the upper urinary tract is usually treated by the insertion of a nephrostomy tube. Chronic upper urinary tract obstruction is treated by the insertion of a ureteric stent or a pyeloplasty.[1][2][3]

Lower urinary tract obstruction (such as that caused by bladder outflow obstruction secondary to prostatic hypertrophy) is usually treated by insertion of a urinary catheter or a suprapubic catheter.

Surgery is not required in all cases.[4]

Indications

  • Surgical intervention is not recommended for the management of [disease name].

OR

  • Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either:
    • [Indication 1]
    • [Indication 2]
    • [Indication 3]
  • The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either:
    • [Indication 1]
    • [Indication 2]
    • [Indication 3]

Surgery

  • The feasibility of surgery depends on the stage of [malignancy] at diagnosis.

OR

  • Surgery is the mainstay of treatment for [disease or malignancy].

Contraindications

References

  1. Liu KL, Lee BC, Ye JD, Chang YH, Chang CC, Huang KH, Lee YJ, Chang YC (July 2018). "Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients". Eur Radiol. doi:10.1007/s00330-018-5560-6. PMID 29974220.
  2. Şimşir A, Kızılay F, Semerci B (April 2018). "Comparison of percutaneous nephrostomy and double J stent in symptomatic pregnancy hydronephrosis treatment". Turk J Med Sci. 48 (2): 405–411. doi:10.3906/sag-1711-5. PMID 29714462. line feed character in |title= at position 61 (help)
  3. Li B, Liu DB, Gong EM (June 2018). "Robot-assisted laparoscopic transplant-to-native ureteroureterostomy of an intraperitoneal renal allograft". J Pediatr Urol. doi:10.1016/j.jpurol.2018.06.008. PMID 30017605.
  4. Onen A (2007). "Treatment and outcome of prenatally detected newborn hydronephrosis". J Pediatr Urol. 3 (6): 469–76. doi:10.1016/j.jpurol.2007.05.002. PMID 18947797. Unknown parameter |month= ignored (help)

Template:WH Template:WS